Novo Nordisk nominates Jan van de Winkel and Ramona Sequeira to board
20/02/2026 12:10
COPENHAGEN, Feb 20 (Reuters) - Novo Nordisk NOVOb.CO said on Friday it would nominate Jan van de Winkel and Ramona Sequeira to its board of directors, the first additions since a shake-up at the Danish obesity drugmaker last year. (Reporting by Stine Jacobsen. Editing by Louise Rasmussen and Mark Potter) ((stine.jacobsen@thomsonreuters.com; +45 2156 9010))
Recent news on Hims
See all newsAs Hims prepares for peptides launch, Wall Street cautious on prospects this year
Announces Oled Display Equipment Supply Contract
Corrected: ANALYSIS-Hims' obesity drug business may get boost as employers drop coverage
Brief: Hims Co To Supply Oled Display Equipment To Chengdu Topway High Tech
Brief: Hims Co Ltd Wins 7.5 Billion Won Order